Clinical Trials Browser

MLN8054 × Clear all

NCT00652158 2013-09-23

A Phase 1 Trial of Extended MLN8054 Dosing in Patients With Advanced Malignancies

Phase 1 Terminated

Advanced Malignancies

NCT00249301 2008-04-01

A Study of MLN8054 in Patients With Advanced Solid Tumors

Phase 1 Terminated

BreastGastrointestinalGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Pancreatic Neoplasms